Acasti Pharma (ACST)
(Delayed Data from NSDQ)
$2.90 USD
-0.03 (-0.97%)
Updated Apr 26, 2024 02:27 PM ET
After-Market: $2.92 +0.02 (0.69%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 6/28/24 |
---|---|
Current Quarter | -0.35 |
EPS Last Quarter | -0.21 |
Last EPS Surprise | 30.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.44 |
Next Year | -1.29 |
EPS (TTM) | -1.04 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.35 | NA | -1.44 | -1.29 |
# of Estimates | 1 | NA | 1 | 1 |
Most Recent Consensus | -0.35 | NA | -1.44 | -1.29 |
High Estimate | -0.35 | NA | -1.44 | -1.29 |
Low Estimate | -0.35 | NA | -1.44 | -1.29 |
Year ago EPS | -0.30 | -0.34 | -2.10 | -1.44 |
Year over Year Growth Est. | -16.67% | NA | 31.43% | 10.42% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | NA | 0 | 0 |
Up Last 30 Days | 0 | NA | 0 | 0 |
Up Last 60 Days | 0 | NA | 0 | 0 |
Down Last 7 Days | 0 | NA | 0 | 0 |
Down Last 30 Days | 0 | NA | 0 | 0 |
Down Last 60 Days | 0 | NA | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Current | -0.35 | NA | -1.44 | -1.29 |
7 Days Ago | -0.35 | NA | -1.44 | -1.29 |
30 Days Ago | -0.35 | NA | -1.44 | -1.29 |
60 Days Ago | -0.35 | NA | -1.44 | -1.29 |
90 Days Ago | -0.35 | NA | -1.44 | -1.29 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.35 | NA | -1.44 | -1.29 |
Zacks Consensus Estimate | -0.35 | NA | -1.44 | -1.29 |
Earnings ESP | 0.00% | NA | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.21 | -0.19 | -0.34 | -0.30 | NA |
Estimate | -0.30 | -0.29 | -0.63 | -0.78 | NA |
Difference | 0.09 | 0.10 | 0.29 | 0.48 | 0.24 |
Surprise | 30.00% | 34.48% | 46.03% | 61.54% | 43.01% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more